Skip to main content
SupplementScience

Benefits of Royal Jelly

Reviewed by·PharmD, BCPS

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Hormonal balance — 10-HDA in royal jelly exhibits estrogen receptor binding activity, and clinical trials in menopausal women show improvements in anxiety, hot flashes, and quality of life scores (Asama et al., 2018)
  • Fertility support — Morita et al. (2012) demonstrated that royal jelly supplementation improved follicular development markers in women undergoing IVF, while animal studies show enhanced testosterone production and sperm quality in males via 10-HDA-mediated pathways
  • Anti-inflammatory and immune modulation — 10-HDA inhibits NF-kB signaling and reduces pro-inflammatory cytokines (TNF-alpha, IL-6) in both cell culture and animal models, with Sugiyama et al. (2012) confirming immunoregulatory effects in human immune cells
  • Cholesterol reduction — a randomized trial by Guo et al. (2007) found that 6 weeks of royal jelly supplementation (6g/day) significantly reduced total cholesterol and LDL in mildly hypercholesterolemic adults
  • Skin health — royal jelly stimulates collagen production and enhances skin moisture when consumed orally or applied topically; Park et al. (2011) found oral supplementation improved skin hydration and reduced wrinkle depth in a controlled study

What the Research Says

Royal jelly research has been driven primarily by Japanese and East Asian researchers. The unique compound 10-hydroxy-2-decenoic acid (10-HDA) is the most studied bioactive, with demonstrated anti-inflammatory, immunomodulatory, and estrogen-like properties. Asama et al. (2018) published a randomized controlled trial in 42 menopausal women showing 800mg/day royal jelly significantly improved menopausal symptom scores over 12 weeks. Guo et al. (2007) found 6g/day reduced total cholesterol and LDL in a 6-week RCT of 36 mildly hypercholesterolemic adults. Morita et al. (2012) reported improved follicular development in IVF patients receiving royal jelly, though the study was small and non-blinded. For skin health, Park et al. (2011) demonstrated improved hydration and reduced wrinkle depth with oral supplementation. Sugiyama et al. (2012) elucidated immunomodulatory mechanisms including NF-kB inhibition. The major limitations include small sample sizes (typically 20-50 participants), predominance of Japanese populations, short study durations, and heterogeneity in royal jelly preparations and 10-HDA content. Allergy risk is the primary safety concern — multiple case reports document anaphylaxis including fatal outcomes.

References

  1. Asama T, Matsuzaki H, Fukushima S, Tatefuji T, Hashimoto K, Takeda T (2018). Royal jelly supplementation improves menopausal symptoms such as backache, low back pain, and anxiety in postmenopausal Japanese women. Evidence-Based Complementary and Alternative Medicine. DOI PubMed
  2. Guo H, Saiga A, Sato M, Miyazawa I, Shibata M, Takahata Y, Morimatsu F (2007). Royal jelly supplementation improves lipoprotein metabolism in humans. Journal of Nutritional Science and Vitaminology. DOI PubMed
  3. Morita H, Ikeda T, Kajita K, Fujioka K, Mori I, Okada H, Uno Y, Ishizuka T (2012). Effect of royal jelly ingestion for six months on healthy volunteers. Nutrition Journal. DOI PubMed
  4. Sugiyama T, Takahashi K, Mori H (2012). Royal jelly acid, 10-hydroxy-trans-2-decenoic acid, as a modulator of the innate immune responses. Endocrine, Metabolic & Immune Disorders Drug Targets. DOI PubMed
  5. Park HM, Cho MH, Cho Y, Kim SY (2011). Royal jelly increases collagen production in rat tendon fibroblasts in vitro and in vivo. Journal of Medicinal Food. DOI PubMed
  6. Kamakura M (2011). Royalactin induces queen differentiation in honeybees. Nature. DOI PubMed
  7. Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D (1996). Asthma and anaphylaxis induced by royal jelly. Clinical & Experimental Allergy. DOI PubMed